NeuBase Therapeutics, Inc. received notice that Franklyn G. Prendergast, M.D., Ph.D., who served as a member of the Company?s Board of Directors since July 2019, passed away. Dr. Prendergast was also a member of the Audit Committee and Compensation Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4396 USD | -0.54% | +2.23% | -40.60% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
1st Jan change | Capi. | |
---|---|---|
-40.60% | 1.65M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NBSE Stock
- News NeuBase Therapeutics, Inc.
- Neubase Therapeutics, Inc. Announces Franklyn G. Prendergast Board of Directors Passed Away